Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for Glucocorticoid-Induced Hyperglycemia in Acute Exacerbation of COPD
NCT02253121Phase 4Completed
- Sponsor
- Slotervaartziekenhuis
- Start
- Feb 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in hyperglycemia, sponsored by Slotervaartziekenhuis. Started Feb 2015; status: completed.
02
Drugs
dapagliflozin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT02253121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02253121.